Literature DB >> 7427916

Cancer in the Sindhi population of Greater Bombay.

D J Jussawalla, B B Yeole, M V Natekar, T R Rajagopalan.   

Abstract

The Sindhis are a Hindu subgroup identified by their place of origin and their written spoken language. These are the people who were originally inhabitants of the Province of Sind, which formed a part of the large Bombay Presidency in Undivided India before 1947. The Sindhi Hindus migrated en masse to India after partition. An attempt has been made here to examine the differences found in the site-specific cancer risks among the Sindhi community, the other Hindu groups (such as the Marathi and Gujrati populations) and the Parsi community of Greater Bombay. As the Indian Census Board does not provide age distribution details for the Sindhis, analysis of the data was undertaken employing frequency ratios. Age-standardized cancer ratios (ASCAR) were also utilized for certain calculations. The common sites of cancer appear to vary greatly between the total Bombay population and the Sindhi group. In Sindhi men, for example, cancers of the lung, large bowel, prostate, kidneys and leukemias are most commmonly seen, whereas laryngeal and oesophageal cancers predominate in the general population of Bombay. In Sindhi women the breast, uterus, ovary, and skin are the preferred sites, whereas cancers of the cervix and leukemias are predominant in the general population of Bombay. It is interesting to note that there is a degree of similarity in the incidence of cancer at certain anatomical sites, such as the prostate, large intestine, and leukemias in males, and breast, cervix, ovary and uterus in females, between the Sindhi and Parsi communities of Greater Bombay.

Entities:  

Mesh:

Year:  1980        PMID: 7427916     DOI: 10.1002/1097-0142(19801101)46:9<2107::aid-cncr2820460933>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Cancer incidence in Indian Christians.

Authors:  D J Jussawalla; B B Yeole; M V Natekar
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.